Peptide analytical method transfer: the documents a buyer should agree
Define the document handover, reporting basis and acceptance responsibilities for peptide analytical method transfer, with ICH Q2(R2), Q14 and WHO references.

For business purchasing and quality teams. References checked 31 October 2026.
Define the purchasing question before commissioning a transfer
Peptide analytical method transfer becomes a purchasing issue when a supplier and a receiving laboratory need results that can support the same supply decision. The order should identify the procedure, material and reporting basis being transferred, together with the organisations responsible for the handover. “Use our HPLC method” is too incomplete to price or approve reliably.
Specify whether the intended outcome concerns identity, assay, impurities or another attribute in the agreed material specification. An identity test, for example, does not establish the amount of peptide supplied. Keep the business reason visible, such as qualifying a new testing site or moving a defined release test to a contracted laboratory.
Identify both organisations
Record the sending and receiving units, their quality contacts and the person authorised to accept the final report. If a supplier appoints a separate contract laboratory, identify that party before the quotation becomes a purchase order. Agree how the buyer can obtain the records needed for its review.
Use the current validation framework with the right scope
FDA’s March 2024 guidance page announces the final Q2(R2) and Q14 documents. They address analytical validation and analytical development, respectively. Record the document editions used in the project brief so that “validated method” has a defined reference.
ICH Q2(R2), section 2.2 addresses transfer within the analytical procedure lifecycle. It describes partial or full revalidation and/or comparative analysis of representative samples when transferring to another laboratory, with justification where additional transfer experiments are omitted. The responsible technical team must choose and document the approach appropriate to the procedure.
For the buyer, this means asking how the proposed transfer conclusion will be supported. A supplier’s existing validation report is one part of the document package. The order should also explain what evidence will support use at the receiving site and who will review any gaps.
Agree a document package that can be reviewed
WHO’s technology-transfer guidance sets out sending- and receiving-unit responsibilities and the content of an analytical transfer protocol. Its framework helps a procurement team identify missing responsibilities before work starts. The table below turns that handover into purchasing questions without prescribing an analytical procedure.
| Record | Buyer’s review question |
|---|---|
| Controlled procedure | Which identifier and revision are included in the contract? |
| Relevant validation information | What evidence supports the procedure’s stated purpose? |
| Transfer plan | Which organisations approve its scope and acceptance criteria? |
| Reference-material records | Which lots and assigned values are applicable? |
| Result package | Which reports and supporting records will be supplied? |
| Deviations and final conclusion | Who resolves exceptions and approves the outcome? |
List expected deliverables in the quotation. Where information is confidential, agree access, review rights and secure document exchange before the work is commissioned. Specify the report contents so the buyer can check delivery against the quoted service.
Compare results on the same reporting basis
Keep the measured attribute explicit
Confirm the units, basis of calculation and specification revision used by each laboratory. A chromatographic area percentage, an assay result and a quantity expressed per container answer different questions. Preserve their original labels in the review record. The purity and material-content guide explains the procurement consequence of confusing these quantities.
Also ask how reference-material identity, lot and assigned value will be recorded in the result package. A change in those inputs can require explanation even when the two reports use the same procedure title. The receiving team needs enough context to assess what the numbers represent.
Agree the decision criteria before seeing the results
Have the responsible quality and analytical teams approve the comparison criteria before execution. A procurement document should identify that approval and the route for handling an inconclusive outcome. Choosing a tolerance after results arrive can turn an unresolved technical difference into an undocumented commercial compromise.
Close the transfer with a usable supply decision
Ask the final report to identify the procedure and sites covered, the evidence reviewed, deviations still open and the authorised conclusion. Keep any conditions visible in the laboratory service agreement and the material’s document register. An acceptance limited to one test or material should remain limited when the next order is placed.
- Confirm that all contracted deliverables have been received.
- Check the final report against the approved plan and revisions.
- Record how exceptions were resolved and by whom.
- Identify the date from which the receiving site can perform the agreed role.
- Assign change notifications for the procedure, site or reference material.
Link the outcome to supply change control and the quality agreement. For an outsourced project, include the testing responsibilities in the CRO/CDMO scope. Send the business objective and required document access through the project enquiry form.
Frequently asked questions
Does an existing validation report complete a method transfer?
The receiving-site conclusion needs its own documented justification. The responsible teams should determine what transfer evidence is needed for the procedure, site and intended purpose.
Should procurement set the analytical acceptance tolerance?
The responsible analytical and quality teams should define and approve technical criteria. Procurement should ensure those criteria and the approval responsibilities are part of the agreed scope.
Can two HPLC reports be compared because both report a percentage?
First check what each percentage measures, its units and reporting basis, procedure revision and applicable reference-material information. Matching symbols alone do not establish comparable results.
What should the final transfer report identify?
It should connect the procedure, material, participating sites, approved plan, reviewed evidence, deviations and authorised conclusion, with any conditions on the accepted scope.